dc.creator | Detsi A., Kavetsou E., Kostopoulou I., Pitterou I., Pontillo A.R.N., Tzani A., Christodoulou P., Siliachli A., Zoumpoulakis P. | en |
dc.date.accessioned | 2023-01-31T07:54:08Z | |
dc.date.available | 2023-01-31T07:54:08Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.3390/pharmaceutics12070669 | |
dc.identifier.issn | 19994923 | |
dc.identifier.uri | http://hdl.handle.net/11615/73239 | |
dc.description.abstract | Chitosan is a cationic natural polysaccharide, which has emerged as an increasingly interesting biomaterialover the past few years. It constitutes a novel perspective in drug delivery systems and nanocarriers’ formulations due to its beneficial properties, including biocompatibility, biodegradability and low toxicity. The potentiality of chemical or enzymatic modifications of the biopolymer, as well as its complementary use with other polymers, further attract the scientific community, offering improved and combined properties in the final materials. As a result, chitosan has been extensively used as a matrix for the encapsulation of several valuable compounds. In this review article, the advantageous character of chitosan as a matrix for nanosystemsis presented, focusing on the encapsulation of natural products. A five-year literature review is attempted covering the use of chitosan and modified chitosan as matrices and coatings for the encapsulation of natural extracts, essential oils or pure naturally occurring bioactive compounds are discussed. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | en |
dc.language.iso | en | en |
dc.source | Pharmaceutics | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088494473&doi=10.3390%2fpharmaceutics12070669&partnerID=40&md5=5c25d185907785fd8bb030f4623caaa8 | |
dc.subject | baicalein | en |
dc.subject | baicalin | en |
dc.subject | carvacrol | en |
dc.subject | Centella asiatica extract | en |
dc.subject | chitosan | en |
dc.subject | chitosan nanoparticle | en |
dc.subject | chlorogenic acid | en |
dc.subject | Cinnamomum cassia extract | en |
dc.subject | citrus oil | en |
dc.subject | clove oil | en |
dc.subject | curcumin | en |
dc.subject | ellagic acid | en |
dc.subject | epigallocatechin gallate | en |
dc.subject | essential oil | en |
dc.subject | ferulic acid | en |
dc.subject | flavonoid | en |
dc.subject | genistein | en |
dc.subject | kaempferol | en |
dc.subject | lavender oil | en |
dc.subject | lupulon | en |
dc.subject | naringenin | en |
dc.subject | natural product | en |
dc.subject | peppermint oil | en |
dc.subject | phenol derivative | en |
dc.subject | polyphenol | en |
dc.subject | quercetin | en |
dc.subject | rosmarinic acid | en |
dc.subject | thyme oil | en |
dc.subject | thymol | en |
dc.subject | unindexed drug | en |
dc.subject | antibacterial activity | en |
dc.subject | antifungal activity | en |
dc.subject | antioxidant activity | en |
dc.subject | cancer inhibition | en |
dc.subject | controlled drug release | en |
dc.subject | drug coating | en |
dc.subject | drug cytotoxicity | en |
dc.subject | drug delivery system | en |
dc.subject | drug distribution | en |
dc.subject | drug efficacy | en |
dc.subject | drug formulation | en |
dc.subject | drug liver level | en |
dc.subject | drug penetration | en |
dc.subject | drug release | en |
dc.subject | drug solubility | en |
dc.subject | drug stability | en |
dc.subject | drug structure | en |
dc.subject | human | en |
dc.subject | nanoencapsulation | en |
dc.subject | nonhuman | en |
dc.subject | particle size | en |
dc.subject | physical chemistry | en |
dc.subject | Review | en |
dc.subject | MDPI AG | en |
dc.title | Nanosystems for the encapsulation of natural products: The case of chitosan biopolymer as a matrix | en |
dc.type | other | en |